Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
ClinicalTrials.gov ID NCT06915766
Sponsor Cogent Biosciences, Inc.
Information provided by Cogent Biosciences, Inc. (Responsible Party)
Trial Information: https://clinicaltrials.gov/study/NCT06915766
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib (POIESIS)
ClinicalTrials.gov ID NCT06479135
Sponsor Kartos Therapeutics, Inc.
Information provided by Kartos Therapeutics, Inc. (Responsible Party)
Trial Information: https://clinicaltrials.gov/study/NCT06479135
